Figures & data
Table 1. Comparison of interspecies differences for a selection of neurotoxicological compounds assessed using in vitro assays. The investigated compound, the parameter that is compared, the animal species that was used and the values derived for the animal species and for humans are indicated. Furthermore, the most sensitive species based on that data and the interspecies differences are shown
IPCS. Chemical-specific adjustment factors for interspecies differences and human variability: guidance document for use of data in dose/concentration-response assessment. Geneva: World Health Organization; 2005. Hibell AD, Kidd EJ, Chessell IP, et al. Apparent species differences in the kinetic properties of P2X7 receptors. Br J Pharmacol. 2000;130(1):167–173. Tukker AM, Van Kleef R, Wijnolts FMJ, et al. Towards animal-free neurotoxicity screening: applicability of hiPSC-derived neuronal models for in vitro seizure liability assessment. ALTEX. 2020;37(1):121–135. Tukker AM, MWGDM DG, Wijnolts FMJ, et al. Is the time right for in vitro neurotoxicity testing using human iPSC-derived neurons? ALTEX. 2016;33(3):261–271. Hondebrink L, Verboven AHA, Drega WS, et al. Neurotoxicity screening of (illicit) drugs using novel methods for analysis of microelectrode array (MEA) recordings. Neurotoxicology. 2016;55:1–9. Tukker AM, Wijnolts FMJ, de Groot A, et al. Applicability of hiPSC-derived neuronal co-cultures and rodent primary cortical cultures for in vitro seizure liability assessment. Toxicol Sci. 2020;178(1):71-87 Tuan EW, Horti AG, Olson TT, et al. AT-1001 is a partial agonist with high affinity and selectivity at human and rat α3β4 nicotinic cholinergic receptors. Mol Pharmacol. 2015;88(4):640–649. Lee S-H, Rhee J, Koh J-K, et al. Species differences in functions of dopamine transporter: paucity of MPP+ uptake and cocaine binding in bovine dopamine transporter. Neurosci Lett. 1996;214(2):199–201. Goldoni M, Vittoria Vettori M, Alinovi R, et al. Models of neurotoxicity: extrapolation of benchmark doses in vitro. Risk Anal. 2003;23(3):505–514. Hondebrink L, Kasteel EEJ, Tukker AM, et al. Neuropharmacological characterization of the new psychoactive substance methoxetamine. Neuropharmacology. 2017;123:1–9. Tukker AM, Wijnolts FMJ, de Groot A, et al. Human iPSC-derived neuronal models for in vitro neurotoxicity assessment. Neurotoxicology. 2018;67:215–225. Dingemans MML, Schütte MG, Wiersma DMM, et al. Chronic 14-day exposure to insecticides or methylmercury modulates neuronal activity in primary rat cortical cultures. Neurotoxicology. 2016;57:194–202. Tukker AM, Bouwman LMS, van Kleef R, et al. Perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) acutely affect human α(1)β(2)γ(2L) GABA(A) receptor and spontaneous neuronal network function in vitro. Sci Rep. 2020;10(1):5311. Kasteel EEJ, Westerink RHS. Comparison of the acute inhibitory effects of Tetrodotoxin (TTX) in rat and human neuronal networks for risk assessment purposes. Toxicol Lett. 2017;270:12–16.